Ark Therapeutics Group PLC Holding(s) in Company (7105X)
February 12 2013 - 7:25AM
UK Regulatory
TIDMAKT
RNS Number : 7105X
Ark Therapeutics Group PLC
12 February 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
----------------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying
issuer Ark Therapeutics Group plc
of existing shares to which voting rights
are
attached: (ii)
------------------------------------------------------------------- -------------------------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
----------------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------------------------------------ --------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
------------------------------------------------------------------------------------------------------------ --------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
------------------------------------------------------------------------------------------------------------ --------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------------------------------ --------
Other (please specify):
--------------------------- ------------------------------------------------------------------------------- --------
3. Full name of person(s) subject Investec Wealth & Investment Limited
to the
notification obligation: (iii)
---------------------------------------------------------- ----------------------------------------------------------
4. Full name of shareholder(s) N/A
(if different from 3.):(iv)
---------------------------------------------------------- ----------------------------------------------------------
5. Date of the transaction and date 6(th) February 2013
on
which the threshold is crossed
or
reached: (v)
---------------------------------------------------------- ----------------------------------------------------------
6. Date on which issuer notified: 11(th) February 2013
---------------------------------------------------------- ----------------------------------------------------------
7. Threshold(s) that is/are crossed
or
reached: (vi, vii) 3%
---------------------------------------------------------- ----------------------------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ----------------------------------- ------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
------------- ---------------- ----------------- --------------- ------------------- ----------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- --- ----- ------ ----- --------------- ------- ---------- ----------- ---------------
Ordinary
Shares
GB0034251727 6,006,503 6,006,503 8,306,503 3.97%
------------- ---------------- ----------------- --------------- ------- ---------- ----------- ---------------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
-------------------- ----------------- -------------------------- ------------------------ -----------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
--------------- -------------- ------------- ------------------- ------------------------ -----------------------
Nominal Delta
--------------- -------------- ------------- ------------------- ------------------------ ------------- --------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------------------- -------------------------------------------------------
8,306,503 3.97%
------------------------------------------------------------- -------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
----------------------------------------------------------------------------------------------------------------------
Client holdings registered in the name of Nominee companies 100% owned
by Investec Wealth & Investment Limited.
Proxy Voting:
----------------------------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
N/A
---------------------------------------------------------------------------- ----------------------------------------
11. Number of voting rights proxy holder will
cease N/A
to hold:
---------------------------------------------------------------------------- ----------------------------------------
12. Date on which proxy holder will cease to
hold N/A
voting rights:
---------------------------------------------------------------------------- ----------------------------------------
13. Additional information: N/A
------------------------------------------------------------- -------------------------------------------------------
14. Contact name:
Phil Beardwell Chartered FCSI
Senior Compliance Manager
------------------------------------------------------------- -------------------------------------------------------
15. Contact telephone number: 020 7597 1356
------------------------------------------------------------- -------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUUUROUAUAAR
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From May 2024 to Jun 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2023 to Jun 2024
